Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") (TARA).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 4.7% ownership in Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") (TARA) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 4.6% | 1,612,531 | 0 | 1,612,531 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 4.6% | 1,612,531 | 0 | 1,612,531 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 4.6% | 1,612,531 | 0 | 1,612,531 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0% | 15,203 | 0 | 15,203 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities Group LP | 0% | 15,203 | 0 | 15,203 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Citadel Securities GP LLC | 0% | 15,203 | 0 | 15,203 | /s/ Guy Miller | Guy Miller, Authorized Signatory | |
| Kenneth Griffin | 4.7% | 1,627,734 | 0 | 1,627,734 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |